OakChart

Cellyan Biotechnology Co Ltd

HKPDHealthcare·Medical Distribution·Hong Kong·Nano·NASD·Nov 11 • 12:01 PM ET

1.60+0.02 (1.32%)
2026-11-11 18:02 CET
Market cap
- USD m
Revenue, TTM
- USD m
Net income, TTM
- USD m
Free cash flow, TTM
- USD m
EPS diluted, TTM
-
P/E
-
Compare

Price

HKPD against its 20, 50 and 200-day averages
2050200
5.0010.0015.0020.002.5M5.0MMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26HKPDclose 1.6020-day 1.9350-day 2.18200-day 8.771.60

94.5% under the 52-week high of 29.00 on 20 Nov 2025. 52-week low 1.34 on 5 Nov 2026. Last 15 sessions, 80.6% high to low

Profile

HKPD
52-week range, 1% of the way up
1.3429.00

Cellyan Biotechnology Ltd. engages in providing pharmaceutical cross-border e-commerce supply chain services. It focuses on cross-border pharmaceutical warehousing, cross-border OTC registration and import, and OTC product wholesale services. The company was founded by Lap Sun Wong on August 17, 2023 and is headquartered in Hong Kong.

Employees11
IPOJan 15, 2025
Beta2.60
ATR, 14d0.29
Rel volume0.09

Snapshot

6 groups

Valuation

Index-
Market Cap3.93M
Enterprise Value-
Income-
Sales-
Book/sh-
Cash/sh-
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees11
IPOJan 15, 2025

Ratios

P/E-
Forward P/E-
PEG-
P/S-
P/B-
P/C-
P/FCF-
EV/EBITDA-
EV/Sales-
Quick Ratio-
Current Ratio-
Debt/Eq-
LT Debt/Eq-
Option/ShortNo / Yes

Earnings

EPS (ttm)-
EPS next Y-
EPS next Q-
EPS this Y-
EPS next Y-
EPS next 5Y-
EPS past 3/5Y- -
Sales past 3/5Y- -
EPS Y/Y TTM-
Sales Y/Y TTM-
EPS Q/Q-
Sales Q/Q-
Earnings-
EPS/Sales Surpr.- -

Ownership

Insider Own-
Insider Trans-
Inst Own-
Inst Trans-
ROA-
ROE-
ROIC-
Gross Margin-
Oper. Margin-
Profit Margin-
SMA20-17.43%
SMA50-26.76%
SMA200-81.80%
Trades-

Technical

Shs Outstand0.82M
Shs Float-
Short Float-
Short Ratio0.09
Short Interest0.02M
52W High29.00 -94.50%
52W Low1.34 19.09%
Volatility21.23% 16.37%
ATR (14)0.29
RSI (14)35.20
Beta2.60
Rel Volume0.09
Avg Volume179.27K
Volume6,524

Performance

Perf Week-13.74%
Perf Month-23.94%
Perf Quarter-81.00%
Perf Half Y-86.69%
Perf YTD-90.32%
Perf Year-93.51%
Perf 3Y-
Perf 5Y-
Perf 10Y-
Recom-
Target Price-
Prev Close1.58
Price1.60
Change %1.32%

Peers

Mkt cap
TickerCompanyMkt cap
YI111 Inc ADR14.48M
COSMCosmos Health Inc21.88M
RDGTRidgetech Inc4.28M
AHGAkso Health Group ADR1.08B
MEDSDataMEDS AI Inc4.27M
POMPomdoctor Ltd13.01M
PRGOPerrigo Company plc2.30B
UPCUniverse Pharmaceuticals INC7.99M
HLNHaleon plc ADR39.88B
CPHIChina Pharma Holdings Inc22.32M

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
No quarterly earnings.

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
No annual earnings.

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
No estimate revisions.

Estimate history

EPS, annual
Period
EPS, quarterly
Period
Sales, annual
Period
Sales, quarterly
Period
Shares, annual
Period
Shares, quarterly
Period

Income statement, annual

No statement data.

Income statement, quarterly

No statement data.

Balance sheet, annual

No statement data.

Cash flow, annual

No statement data.

Balance sheet, quarterly

No statement data.

Cash flow, quarterly

No statement data.

Revenue breakdown

Revenue split-

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-30-0.0M-177.33K
2026-10-15-0.0M-186.86K
2026-09-30-0.0M-185.57K
2026-09-15-0.0M-170.75K
2026-08-31-0.0M-36.85K
2026-08-14-0.0M-36.65K
2026-07-31-0.0M-41.48K
2026-07-15-0.0M-18.41K
2026-06-30-0.0M-17.99K
2026-06-15-0.0M-17.49K
2026-05-29-0.0M-6.39K
2026-05-15-0.0M-6.51K
2026-04-30-0.0M-1.91K
2026-04-15-0.0M-2.01K
2026-03-31-0.0M-2.10K
2026-03-13-0.0M-2.09K
2026-02-27-0.0M-4.07K
2026-02-13-0.0M-5.18K
2026-01-30-0.0M-5.25K
2026-01-15-0.0M-7.32K

Option chain

expiry 2026-11-11
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
No option chain for this symbol.

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-10-216-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-10-21SEC
2026-09-246-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-09-23SEC
2026-09-236-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-09-23SEC
2026-09-106-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-09-09SEC
2026-08-13S-8Initial registration statement for securities to be offered to employees pursuant to employee benefit plansSEC
2026-08-0720-FRegistration statement under Section 12 of the Securities Exchange Act of 1934 or an annual or transition report filed under Section 13(a) or 15(d) of the Exchange Act for a foreign private issuer.2026-03-31SEC
2026-07-31NT 20-F2026-03-31SEC
2026-07-166-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-07-16SEC
2026-06-24EFFECTEffectiveness filing by commission orderSEC
2026-06-12F-3Registration statement for specified transactions by certain foreign private issuersSEC
2026-06-123Initial statement of beneficial ownership of securities2026-03-18SEC
2026-06-103Initial statement of beneficial ownership of securities2026-03-18SEC
2026-06-093Initial statement of beneficial ownership of securities2026-03-18SEC
2026-06-083Initial statement of beneficial ownership of securities2026-03-18SEC
2026-06-083Initial statement of beneficial ownership of securities2026-03-18SEC
2026-06-083Initial statement of beneficial ownership of securities2026-03-18SEC
2026-06-083Initial statement of beneficial ownership of securities2026-03-18SEC
2026-04-08EFFECTEffectiveness filing by commission orderSEC
2026-04-06CORRESPSEC
2026-04-02UPLOADUpload SubmissionSEC
2026-03-27F-1Registration statement for certain foreign private issuersSEC
2026-03-276-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-03-26SEC
2026-03-186-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162025-09-30SEC
2026-01-166-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-01-16SEC
2025-12-316-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162025-12-30SEC
2025-12-176-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162025-12-17SEC
2025-11-246-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162025-11-24SEC
2025-11-126-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162025-11-12SEC
2025-11-12SCHEDULE 13DSEC
2025-10-076-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162025-10-06SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-080000
2026-070000
2026-060000
2026-050000
2026-040000
2026-030000
2026-020000
2026-010000
2025-120000
2025-110000

Institutional holders

Manager% owned
-

Funds

Fund% owned
-

OakChart. HKPD. Cached 15 minutes.

Some panels did not load: ratings, insider, news.